Stay updated on Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2. No changes to study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-11T17:57:17.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and a government funding/operating status notice was removed. These are maintenance updates rather than changes to trial data or core content.
    Difference
    0.4%
    Check dated 2026-02-11T02:01:12.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding notice banner was added and the page now displays a version banner showing v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:37:58.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now shows a glossary (Show glossary) and new metadata lines: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. It also removes 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T00:23:49.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-13T18:46:49.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3. Removed the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry.
    Difference
    0.1%
    Check dated 2025-12-23T07:32:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial page.